Acasti Pharma, Inc. (NASDAQ:ACST)

About the company

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

None

$0.00M

Total Revenue

None

Employees

$19.36M

Market Capitalization

-0.92

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 16945.16 1518.00 7.46 30.51 34.09
Catalent, Inc. CTLT 12900.24 3094.00 4.81 74.45 5.59
Jazz Pharmaceuticals Plc JAZZ 8088.30 2217.00 2.50 61.43 6.01
Perrigo Co. Plc PRGO 6448.59 5074.00 1.09 26.90 4.73
MyoKardia, Inc. MYOK 6418.32 34.00 7.97 -18.99 -201.73
Bausch Health Cos., Inc. BHC 6068.07 8109.00 12.83 -2.96 -25.19
United Therapeutics Corp. UTHR 4650.36 1431.00 1.52 10.84 30.04
SAGE Therapeutics, Inc. SAGE 3247.40 9.00 4.39 -5.29 -413.06
Axsome Therapeutics, Inc. AXSM 2939.40 None 19.77 -30.81 None
Pacira Biosciences, Inc. PCRX 2552.34 408.00 6.69 -243.08 -2.47
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2212.77 351.00 4.58 19.14 32.49
Prestige Consumer Healthcare, Inc. PBH 1849.77 960.00 1.48 12.13 15.84
Madrigal Pharmaceuticals, Inc. MDGL 1843.20 0.00 5.53 -14.11 -624.74
Revolution Medicines, Inc. RVMD 1825.46 46.00 5.66 -21.49 -183.83
Ironwood Pharmaceuticals, Inc. IRWD 1580.00 427.00 -43.48 16.13 22.74
Revance Therapeutics, Inc. RVNC 1565.55 0.00 8.23 -7.55 41.82
Intercept Pharmaceuticals, Inc. ICPT 1382.70 283.00 -17.53 -4.05 -119.73
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Innoviva, Inc. INVA 1307.41 299.00 2.57 5.64 76.18
Supernus Pharmaceuticals, Inc. SUPN 1206.90 424.00 1.77 10.16 27.85
Zogenix, Inc. ZGNX 1162.08 5.00 3.31 -2.54 -241.62
Theravance Biopharma, Inc. TBPH 1051.38 77.00 -5.59 -3.87 -351.55
Amphastar Pharmaceuticals, Inc. AMPH 958.93 334.00 2.34 244.62 1.21
Endo International Plc ENDP 749.80 3002.00 -1.05 -4.53 -5.25
BellRing Brands, Inc. BRBR 742.17 920.00 -0.35 5.48 14.84
Collegium Pharmaceutical, Inc. COLL 687.82 302.00 4.49 -2023.00 0.07
Intersect ENT, Inc. XENT 561.92 85.00 6.46 -9.19 -71.96
Aerie Pharmaceuticals, Inc. AERI 561.20 82.00 6.32 -2.77 -247.36
Eagle Pharmaceuticals, Inc. EGRX 557.62 177.00 2.95 -120.70 -2.54
Albireo Pharma, Inc. ALBO 544.60 11.00 8.29 -6.60 -722.91
Assembly Biosciences, Inc. ASMB 540.64 52.00 2.15 -6.98 -136.24
Anika Therapeutics, Inc. ANIK 511.56 126.00 1.80 46.85 9.03
Qualigen Therapeutics, Inc. QLGN 449.00 17634.00 0.12 -14.48 -0.18
BioDelivery Sciences International, Inc. BDSI 398.86 137.00 4.85 58.14 4.23
ANI Pharmaceuticals, Inc. ANIP 364.32 198.00 1.95 -17.86 -10.21
Catalyst Pharmaceuticals, Inc. CPRX 359.52 120.00 3.14 8.62 34.87
MEI Pharma, Inc. MEIP 322.14 29.00 5.06 -6.94 -159.15
Agile Therapeutics, Inc. AGRX 266.00 None 4.09 -9.27 None
Marinus Pharmaceuticals, Inc. MRNS 259.50 0.00 4.55 -3.53 None
Cassava Sciences, Inc. SAVA 211.47 41.00 10.38 -45.77 76.71
Ampio Pharmaceuticals, Inc. AMPE 145.70 1.00 23.50 -6.71 None
Cerecor, Inc. CERC 141.78 7.00 4.21 -4.96 -530.21
Adamas Pharmaceuticals, Inc. ADMS 133.28 64.00 -5.53 -1.71 -122.52
AcelRx Pharmaceuticals, Inc. ACRX 125.60 4.00 -2.34 -2.53 -644.25
Evoke Pharma, Inc. EVOK 118.08 397.00 -492.00 -10.47 -0.76
Mallinckrodt Plc MNK 115.08 2381.00 0.12 -0.05 -89.95
Aclaris Therapeutics, Inc. ACRS 90.20 4.00 1.58 -0.65 None
Zynerba Pharmaceuticals, Inc. ZYNE 88.80 0.00 1.46 -2.01 -699.94
Aclaris Therapeutics, Inc. ACRS 86.92 4.00 1.53 -0.63 None
CTI BioPharma Corp. CTIC 71.19 2.00 1.47 -1.64 -111.83
Lipocine, Inc. LPCN 59.57 0.00 8.05 -3.29 None
Oramed Pharmaceuticals, Inc. ORMP 53.96 3.00 1.96 -4.98 -398.34
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.04 -10.41 -10.33
Natural Alternatives International, Inc. NAII 47.39 114.00 0.65 -12.54 -3.19
SCYNEXIS, Inc. SCYX 42.72 0.00 8.90 -1.10 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Neos Therapeutics, Inc. NEOS 33.20 62.00 -2.01 -1.75 -30.64
PLx Pharma, Inc. PLXP 29.97 0.00 -1.87 -5.84 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
Tonix Pharmaceuticals Holding Corp. TNXP 21.16 None 2.24 0.48 None
Intec Pharma Ltd. NTEC 19.53 None 1.41 -0.31 None
Acasti Pharma, Inc. ACST 19.36 0.00 2.00 -0.92 -611.47
Hepion Pharmaceuticals, Inc. HEPA 17.00 None 1.85 0.44 None
Sonoma Pharmaceuticals, Inc. SNOA 15.80 22.00 1.40 -3.97 -12.24
EyeGate Pharmaceuticals, Inc. EYEG 15.20 3.00 2.25 -1.40 -264.21
Regulus Therapeutics, Inc. RGLS 13.20 0.00 2.29 -0.58 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 11.00 8.00 0.59 -0.13 -798.18
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 4.21 73.00 -0.09 -0.14 -39.28
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer

4d ago, source: YAHOO!

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has appointed seasoned financial executive Brian D. Ford as its Chief Financial Officer, effective ...

New finance chief at Acasti Pharma

4d ago, source: Seeking Alpha

(NASDAQ:ACST) appoints Brian D. Ford as its Chief Financial Officer, effective September 14, 2020. Mr. Ford assumes the responsibilities formerly held by Jean-Francois Boily, Vice-President, Finance, ...

Acasti Announces Filing and Mailing of Information Circular and Change in Record Date

9d ago, source: Business Insider

(GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has filed and mailed the information circular and management proxy statement (the ...

Stocks in Play: Acasti Pharma Inc.

8d ago, source: MarketWatch

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center. The MarketWatch ...

Acasti Announces Filing and Mailing of Information Circular and Change in Record Date

8d ago, source: YAHOO!

LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has filed and mailed the information ...

Acasti Announces Filing and Mailing of Information Circular and Change in Record Date

6d ago, source: Stockhouse

LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has filed ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.